Estrogen receptor beta in prostate cancer.
Imamov
Otabek
O
Lopatkin
Nikolay A
NA
Gustafsson
Jan-Ake
JA
D058891:5-alpha Reductase Inhibitors; D015113:Androstane-3,17-diol / Q000378:metabolism*; D000818:Animals; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D047629:Estrogen Receptor beta / Q000819:agonists / Q000378:metabolism*; D018120:Finasteride / Q000627:therapeutic use; D006801:Humans; D008024:Ligands; D008297:Male; D051379:Mice; D011471:Prostatic Neoplasms / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control*
D058891:5-alpha Reductase Inhibitors; D018931:Antineoplastic Agents, Hormonal; D047629:Estrogen Receptor beta; D008024:Ligands; D015113:Androstane-3,17-diol; D018120:Finasteride